Hong Kong stocks rise on Budweiser earnings, mainland liquidity while CanSino drags vaccine makers lower on patent risks
- Hang Seng Index added 0.8 per cent as Budweiser surged by the most since November on earnings turnaround
- Vaccine stocks plunged following support from Biden’s team for a proposal to waive intellectual protections to help fight the global pandemic

The Hang Seng advanced 0.8 per cent to 28,637.46. The Shanghai Composite slipped 0.2 per cent at the close of trading, while the CSI 300 index of the biggest stocks in Shanghai and Shenzhen tumbled 1.2 per cent, pummelled by deep losses in local vaccine makers.
Budweiser soared 4.9 per cent to HK$25.50 for its biggest one-day gain in more than five months, after rising as much as 9.1 per cent. Asia-Pacific’s biggest brewer by sales recorded US$233 million of earnings last quarter, reversing a US$41 million loss a year earlier, according to an exchange filing on Thursday.
Trading volume amounted to HK$161 billion on Thursday, according to exchange data, versus the daily average of HK$96 billion in the previous three days this week when mainland markets were shut for Labour Day.